1,806
Views
19
CrossRef citations to date
0
Altmetric
Articles

The benefits of folic acid-modified gold nanoparticles in CT-based molecular imaging: radiation dose reduction and image contrast enhancement

, , , , , , & ORCID Icon show all
Pages 1993-2001 | Received 12 Aug 2017, Accepted 18 Nov 2017, Published online: 12 Dec 2017

References

  • Zhou B, Yang J, Peng C, et al. PEGylated polyethylenimine-entrapped gold nanoparticles modified with folic acid for targeted tumor CT imaging. Colloids Surf B Biointerfaces. 2016;140:489–496.
  • Chen Q, Li K, Wen S, et al. Targeted CT/MR dual mode imaging of tumors using multifunctional dendrimer-entrapped gold nanoparticles. Biomaterials. 2013;34:5200–5209.
  • Liu H, Wang H, Guo R, et al. Size-controlled synthesis of dendrimer-stabilized silver nanoparticles for X-ray computed tomography imaging applications. Polym Chem. 2010;1:1677–1683.
  • Popovtzer R, Agrawal A, Kotov NA, et al. Targeted gold nanoparticles enable molecular CT imaging of cancer. Nano Lett. 2008;8:4593.
  • Yordanov AT, Lodder AL, Woller EK, et al. Novel iodinated dendritic nanoparticles for computed tomography (CT) imaging. Nano Lett. 2002;2:595–599.
  • Lin J, Chen X, Huang P. Graphene-based nanomaterials for bioimaging. Adv Drug Deliv Rev. 2016;105:242–254.
  • Ryu JH, Lee S, Son S, et al. Theranostic nanoparticles for future personalized medicine. J Control Release. 2014;190:477–484.
  • Liu Y, Zhang N. Gadolinium loaded nanoparticles in theranostic magnetic resonance imaging. Biomaterials. 2012;33:5363–5375.
  • Hainfeld J, Slatkin D, Focella T, et al. Gold nanoparticles: a new X-ray contrast agent. Br J Radiol. 2006;79(939):248–253.
  • Rana S, Bajaj A, Mout R, et al. Monolayer coated gold nanoparticles for delivery applications. Adv Drug Deliv Rev. 2012;64:200–216.
  • Connor EE, Mwamuka J, Gole A, et al. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small. 2005;1:325–327.
  • Hirsjarvi S, Passirani C, Benoit JP. Passive and active tumour targeting with nanocarriers. Curr Drug Discov Technol. 2011;8:188–196.
  • Byrne JD, Betancourt T, Brannon-Peppas L. Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv Drug Deliv Rev. 2008;60:1615–1626.
  • Ghaznavi H, Hosseini-Nami S, Kamrava SK, et al. Folic acid conjugated PEG coated gold–iron oxide core–shell nanocomplex as a potential agent for targeted photothermal therapy of cancer. Artif Cells, Nanomed Biotechnol. 2017 [Oct 10];[1–11]. doi: 10.1080/21691401.2017.1384384
  • Chiani M, Norouzian D, Shokrgozar MA, et al. Folic acid conjugated nanoliposomes as promising carriers for targeted delivery of bleomycin. Artif Cells, Nanomed Biotechnol. 2017 [Jun 23];[1–7]. doi: 10.1080/21691401.2017.1337029
  • Shakeri-Zadeh A, Eshghi H, Mansoori G, Hashemian A. Gold nanoparticles conjugated with folic acid using mercaptohexanol as the linker. J Nanotechnol Progr Int. 2009;1:13–23.
  • Hashemian A, Eshghi H, Mansoori G, et al. Folate-conjugated gold nanoparticles (synthesis, characterization and design for cancer cells nanotechnology-based targeting). Int J Nanosci Nanotechnol. 2009;5:25–34.
  • Mansoori GA, Brandenburg KS, Shakeri-Zadeh A. A comparative study of two folate-conjugated gold nanoparticles for cancer nanotechnology applications. Cancers. 2010;2:1911–1928.
  • Samadian H, Hosseini-Nami S, Kamrava SK, et al. Folate-conjugated gold nanoparticle as a new nanoplatform for targeted cancer therapy. J Cancer Res Clin Oncol. 2016;142:2217–2229.
  • Peng C, Qin J, Zhou B, et al. Targeted tumor CT imaging using folic acid-modified PEGylated dendrimer-entrapped gold nanoparticles. Polym Chem. 2013;4:4412–4424.
  • Wang H, Zheng L, Peng C, et al. Folic acid-modified dendrimer-entrapped gold nanoparticles as nanoprobes for targeted CT imaging of human lung adencarcinoma. Biomaterials. 2013;34:470–480.
  • McCollough CH, Bruesewitz MR, Kofler JM Jr, CT dose reduction and dose management tools: overview of available options 1. Radiographics. 2006;26:503–512.
  • Corona EC, Ferreira I-BG, Herrera JG, et al. Verification of CTDI and DLP values for a head tomography reported by the manufacturers of the CT scanners, using a CT dose profiler probe, a head phantom and a piranha electrometer. INIS. 2015;47(7):INIS-MX–2946.
  • Kalender WA, Wolf H, Suess C, et al. Dose reduction in CT by on-line tube current control: principles and validation on phantoms and cadavers. Eur Radiol. 1999;9:323–328.
  • Li G, Li D, Zhang L, et al. One‐step synthesis of folic acid protected gold nanoparticles and their receptor‐mediated intracellular uptake. Chem Eur J. 2009;15:9868–9873.
  • Neshastehriz A, Tabei M, Maleki S, et al. Photothermal therapy using folate conjugated gold nanoparticles enhances the effects of 6MV X-ray on mouth epidermal carcinoma cells. J Photochem Photobiol B. 2017;172:52–60.
  • Shope TB, Gagne RM, Johnson GC. A method for describing the doses delivered by transmission x-ray computed tomography. Med Phys. 1981;8:488–495.
  • Dou Y, Guo Y, Li X, et al. Size-tuning ionization to optimize gold nanoparticles for simultaneous enhanced CT imaging and radiotherapy. ACS Nano. 2016;10:2536–2548.
  • Tripathi R, Shrivastav A, Shrivastav B. Biogenic gold nanoparticles: as a potential candidate for brain tumor directed drug delivery. Artif Cells Nanomed Biotechnol. 2015;43:311–317.
  • Al Zaki A, Cormode D, Tsourkas A, et al. Increasing the therapeutic efficacy of radiotherapy using nanoparticles. In: Tofilon P, Camphausen K, editors. Increasing the therapeutic ratio of radiotherapy (Cancer Drug Discovery and Development). Switzerland: Humana Press; 2017. p. 241–265.
  • Bergs JW, Wacker MG, Hehlgans S, et al. The role of recent nanotechnology in enhancing the efficacy of radiation therapy. Biochim Biophys Acta. 2015;1856:130–143.
  • Kim D, Park S, Lee JH, et al. Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging. J Am Chem Soc. 2007;129:7661–7665.
  • Daraee H, Eatemadi A, Abbasi E, et al. Application of gold nanoparticles in biomedical and drug delivery. Artif Cells Nanomed Biotechnol. 2016;44:410–422.
  • Beik J, Abed Z, Ghoreishi FS, et al. Nanotechnology in hyperthermia cancer therapy: from fundamental principles to advanced applications. J Control Release. 2016;235:205–221.
  • Beik J, Khademi S, Attaran N, et al. A nanotechnology based strategy to increase the efficiency of cancer diagnosis and therapy: folate conjugated gold nanoparticles. Curr Med Chem. 2017. doi: 10.2174/0929867324666170810154917
  • Zhou F, Feng B, Yu H, et al. Cisplatin prodrug-conjugated gold nanocluster for fluorescence imaging and targeted therapy of the breast cancer. Theranostics. 2016;6:679.
  • Gao B, Shen L, He KW, et al. GNRs@ SiO2-FA in combination with radiotherapy induces the apoptosis of HepG2 cells by modulating the expression of apoptosis-related proteins. Int J Molecular Med. 2015;36:1282–1290.
  • Mehdizadeh A, Pandesh S, Shakeri-Zadeh A, et al. The effects of folate-conjugated gold nanorods in combination with plasmonic photothermal therapy on mouth epidermal carcinoma cells. Lasers Med Sci. 2014;29:939–948.
  • Shakeri-Zadeh A, Mansoori GA. editors. Cancer Nanotechnology Treatment through Folate Conjugated Gold, Nanoparticles. Proceedings of WCC; 2010.
  • Hu Y, Wang R, Wang S, et al. Multifunctional Fe3O4@ Au core/shell nanostars: a unique platform for multimode imaging and photothermal therapy of tumors. Scientific Rep. 2016;6:28325.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.